- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 219 results
Client Alert
February 9, 2026
FTC’s “Landmark” Settlement with Pharmacy Benefit Manager Express Scripts: Impact on Pharma
Client Alert
February 6, 2026
OFSI To Introduce New Enforcement Framework
Client Alert
February 3, 2026
The QMSR Goes Live and FDA Implements a New Medical Device Inspection Technique
Client Alert
January 30, 2026
U.S. Government Issues General License Authorizing Transactions Involving Venezuelan Oil
Client Alert
January 15, 2026
FTC Announces 2026 Jurisdictional Threshold Updates for Interlocking Directorates and HSR Filing Thresholds
Client Alert
January 13, 2026
Ninth Circuit Hears Oral Argument on California’s SB 253 and SB 261 Climate Disclosure Rules
Client Alert
January 9, 2026
FY 2026 NDAA: Domestic Sourcing, Artificial Intelligence, Cybersecurity, and Acquisition Reforms
Client Alert
January 9, 2026
Leveraging the False Claims Act to Target Corporate DEI Programs
Client Alert
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
Client Alert
January 6, 2026
HHS-OIG Paves Way for New Discount Types with Advisory Opinion 25-11
Client Alert
December 19, 2025
President Trump Signs Executive Order to Reschedule Marijuana, Easing Research and Business Restrictions
Article · Source: Thomson Reuters Westlaw Today
December 16, 2025
USTR Requests Comments For Special 301 Intellectual Property Review